Početna › Ulcerativni kolitis › Pennsylvania
Kliničke studije za Ulcerativni kolitis u državi Pennsylvania
12 studija za Ulcerativni kolitis traži sudionike na lokacijama u državi Pennsylvania.
Gradovi u državi Pennsylvania
Službeni tekst studije (engleski)
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- The Children's Hospital of Philadelphia /ID# 273222, Philadelphia
- Upmc Children'S Hospital Of Pittsburgh /ID# 272328, Pittsburgh
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07071519A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Susquehanna Research Group, Harrisburg
- Penn State Milton S Hershey Medical Ctr, Hershey
- University of Pennsylvania, Philadelphia
- i još 1
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
U tijeku regrutacijaFaza 3
Od 2 do 19 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT04844606A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Allegheny Health Network, Wexford
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06095128An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Penn State Milton S. Hershey Medical Center - Site Number: 8400066, Hershey
- University of Pennsylvania School of Medicine - Site Number: 8400072, Philadelphia
- The Allegheny Health Network (AHN) Center for Digestive Health - Site Number: 8400107, Pittsburgh
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 20. kol 2026. · NCT07184996Inflammatory Bowel Disease (IBD) Research Registry
- University of Pittsburgh Medical Center, Pittsburgh
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 12. kol 2026. · NCT04243525BOOM-IBD2 Pivotal Clinical Trial
- Pennsylvania Hospital, Philadelphia
U tijeku regrutacija
Od 18 do 85 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06571669A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Penn State Health Milton South Hershey Medical Center, Hershey
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 22. lip 2026. · NCT06405087Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- UPMC Hillman Cancer Center, Pittsburgh
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 16. tra 2026. · NCT07223424Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Allegheny Health, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
U tijeku regrutacija
Od 18 do 85 godina · Oba spola · Ažurirano 8. sij 2026. · NCT05987852Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.